Drug profile · INN
guanadrel sulfate
HYLOREL
guanadrel sulfate (HYLOREL) is a norepinephrine transporter substrate. Route of administration: oral. Current US regulatory status: approved.
Drug details — guanadrel sulfate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
guanadrel sulfate (HYLOREL) is a norepinephrine transporter substrate. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Norepinephrine transporter substrate
Primary target: Sodium-dependent noradrenaline transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is guanadrel sulfate?
guanadrel sulfate (HYLOREL) is a norepinephrine transporter substrate. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for guanadrel sulfate?
HYLOREL is a marketed brand name for guanadrel sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of guanadrel sulfate?
guanadrel sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.